TY  - JOUR
AU  - Maiwald, Christian A
AU  - Annink, Kim V
AU  - Rüdiger, Mario
AU  - Benders, Manon J N L
AU  - van Bel, Frank
AU  - Allegaert, Karel
AU  - Naulaers, Gunnar
AU  - Bassler, Dirk
AU  - Klebermaß-Schrehof, Katrin
AU  - Vento, Maximo
AU  - Guimarães, Hercilia
AU  - Stiris, Tom
AU  - Cattarossi, Luigi
AU  - Metsäranta, Marjo
AU  - Vanhatalo, Sampsa
AU  - Mazela, Jan
AU  - Metsvaht, Tuuli
AU  - Jacobs, Yannique
AU  - Franz, Axel R
AU  - ALBINO Study Group
PY  - 2019
DO  - 10.1186/s12887-019-1566-8
UR  - https://hdl.handle.net/10668/25279
T2  - BMC pediatrics
AB  - Perinatal asphyxia and resulting hypoxic-ischemic encephalopathy is a major cause of death and long-term disability in term born neonates. Up to 20,000 infants each year are affected by HIE in Europe and even more in regions with lower level of...
LA  - en
KW  - Allopurinol
KW  - Brain injury
KW  - Cerebral palsy
KW  - Childbirth outcome
KW  - Hypothermia therapy
KW  - Hypoxic-ischemic encephalopathy
KW  - Neonatal oxygen deficiency
KW  - Perinatal asphyxia
KW  - Allopurinol
KW  - Antimetabolites
KW  - Clinical Trials, Phase III as Topic
KW  - Combined Modality Therapy
KW  - Double-Blind Method
KW  - Gestational Age
KW  - Humans
KW  - Hypothermia, Induced
KW  - Hypoxia-Ischemia, Brain
KW  - Infant
KW  - Infant, Newborn
KW  - Multicenter Studies as Topic
KW  - Neurodevelopmental Disorders
KW  - Randomized Controlled Trials as Topic
TI  - Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III).
TY  - research article
VL  - 19
ER  -